Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling

Leandro Cerchietti, MD, Giorgio Inghirami, MD, Nikita Kotlov, PhD, Viktor Svekolkin, PhD, Alexander Bagaev, PhD, Felix Frenkel, PhD, Maria Victoria Revuelta, PhD, Jude M Phillip, PhD, Maria Teresa Cacciapuoti, MS, Sarah C. Rutherford, MD, Peter Martin, FRCPC, MD MS, John P. Leonard, MD

Blood (2019) 134 (Supplement_1): 656.

https://doi.org/10.1182/blood-2019-128889

Published: 2019

Journal Articles

Single Cell Transcriptomic Analysis of the Multiple Myeloma Bone Marrow Identifies a Unique Inflammatory Stromal Cell Population Associated with TNF Signaling

Madelon M.E. de Jong, MD, Zoltan Kellermayer, MD PhD, Natalie Papazian, M Duin, Annemiek Broyl, MD PhD, Pieter Sonneveld, Tom Cupedo

Blood (2019) 134 (Supplement_1): 690.

https://doi.org/10.1182/blood-2019-123012

Published: 2019

Journal Articles

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Chloe B. Steen, MSc, Bogdan A. Luca, PhD, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, PhD, Brian Sworder, MD PhD, Farshad Farshidfar, MD PhD, Kiarash Shamardani, BA, David M. Kurtz, MD PhD, Chih Long Liu, PhD, Ranjana H Advani, MD, Yasodha Natkunam, MD PhD, June Helen Myklebust, PhD, Maximilian Diehn, MD PhD, Andrew Gentles, PhD, Aaron M Newman, PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 655.

https://doi.org/10.1182/blood-2019-129461

Published: 2019

Journal Articles

Lyn Kinase Contributes to the Reprogramming of Fibroblasts Promoting Chronic Lymphocytic Leukemia Progression

Alexander Frederik Vom Stein, Maximilian Koch, Sebastian Reinarzt, Anna Lucas, Rocio Rebollido-Rios, PhD, Thomas Oellerich, MD, Phuong Hien Nguyen, PhD, Michael Hallek

Blood (2019) 134 (Supplement_1): 4283.

https://doi.org/10.1182/blood-2019-129299

Published: 2019

Journal Articles

Heme Oxygenase-1 in Leukemia Cells Promotes Cancer Associated Fibroblasts Mediating Progression of Acute Lymphoblastic Leukemia

Chengyun Pan, Dan Ma, MD, Qin Fang, Ping Liu, Jishi Wang, PhD

Blood (2019) 134 (Supplement_1): 3958.

https://doi.org/10.1182/blood-2019-130440

Published: 2019

Journal Articles

Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma

Reona Sakemura, MD PhD, Michelle J. Cox, Michael J. Hansen, Mehrdad Hefazi, MD, Claudia Manriquez Roman, Kendall J. Schick, Erin E. Tapper, Paulina Roman Moreno, MD, Michael W. Ruff, MD, Denise K Walters, PhD BSc, Sameer A. Parikh, MD, Neil E. Kay, MD, Saad S. Kenderian, MD

Blood (2019) 134 (Supplement_1): 865.

https://doi.org/10.1182/blood-2019-123277

Published: 2019

Journal Articles

Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress

Blood (2019) 134 (17): 1415–1429.

https://doi.org/10.1182/blood.2019001398

Published: 2019

Includes: Supplemental data

Journal Articles

Exosomes Derived from Cancer Associated Fibroblasts Elicit Survival and Drug Resistance of Primary Lymphoma Cells

Shunsuke Kunou, Kazuyuki Shimada, MD PhD, Tomoya Hikita, PhD, Tomohiro Aoki, MD PhD, Akihiko Sakamoto, PhD, Fumihiko Hayakawa, MD, PhD, Chitose Oneyama, PhD, Hitoshi Kiyoi, MD PhD

Blood (2018) 132 (Supplement 1): 4128.

https://doi.org/10.1182/blood-2018-99-111863

Published: 2018

Journal Articles

Extracellular Vesicles (EVs) Shape the Leukemic Microenvironment

Theo Borgovan, MD BS, Chibuikem Chukwudalu Nwizu, Laura R Goldberg, MD PhD, Mark S Dooner, Sicheng Wen, MD PhD, Mike Deltatto, Lorin Crawford, PhD, Peter J. Quesenberry, MD

Blood (2018) 132 (Supplement 1): 5428.

https://doi.org/10.1182/blood-2018-99-118955

Published: 2018

Journal Articles

Diffuse Large B-Cell Lymphoma Remodels the Fibroblastic Reticular Network That Acquires Aberrant Immunosuppressive Capabilities; Implications for the Regulation of Anti-Tumor Immunity in the Immuno-Oncology Era

Benedetta Apollonio, PhD, Peter Jarvis, MSc, Beth Phillips, MBBS, FRCPath, BSc, Andrea Kuhnl, Jon Salisbury, Georgios Zacharioudakis, Lesley-Ann Sutton, Richard Rosenquist, MD PhD, Ruth Jarrett, MBBChir, FRCPath, FRCP, Rose-Marie Amini, Anna Vardi, MD PhD, Alan G. Ramsay, BSc,MSc,PhD

Blood (2018) 132 (Supplement 1): 675.

https://doi.org/10.1182/blood-2018-99-116409

Published: 2018

Journal Articles

Commonly Used Chemotherapy Drugs Differentially Determine Microenvironment-Mediated Protection, Via Mitochondrial Transfer, to B-Precursor Acute Lymphoblastic Leukaemia Cells

Richard J Burt, MBBS, Aditi Dey, PhD, Kenton Cheuk Yan Ng, BSc, Erik Sahai, PhD, Adele K Fielding, MBBS, PhD FRCP, FRCPath

Blood (2018) 132 (Supplement 1): 2690.

https://doi.org/10.1182/blood-2018-99-113370

Published: 2018

Journal Articles

Heat Shock Factor 1 Reprograms the DLBCL Microenvironment to Evade Immune Surveillance and Support Tumor Growth

Jude M Phillip, DPhil, Maria Nieves Calvo Vidal, PhD, Maria Victoria Revuelta, PhD, Nahuel Zamponi, PhD, Stephen Sloan, Benet Pera Gresely, PhD, Tharu Fernando, PhD, Wayne Tam, MD PhD, Giorgio Inghirami, MD, Lawrence Bonassar, PhD, Ari M. Melnick, MD, Leandro Cerchietti, MD

Blood (2018) 132 (Supplement 1): 2854.

https://doi.org/10.1182/blood-2018-99-117774

Published: 2018

Journal Articles

Tumor-Derived LOXL2 Is Highly Expressed in Myelofibrosis and Activating Mesenchymal Stem Cells Differentiate into Cancer Associated Fibroblasts In Vitro

Na Xu, PhD, Chengyun Pan, Xuan Zhou, PhD, Jixian Huang, Yangqing Lan, Bolin He, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5289.

https://doi.org/10.1182/blood.V130.Suppl_1.5289.5289

Published: 2017

Journal Articles

Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance

Richard J Burt, MBBS, Aditi Dey, PhD, Kenton Cheuk Yan Ng, BSc, Bingjie Liu, MSc, Teresa Marafioti, MD, Erik Sahai, PhD, Adele K Fielding, MBBS,PhDFRCP,FRCPath

Blood (2017) 130 (Supplement 1): 1165.

https://doi.org/10.1182/blood.V130.Suppl_1.1165.1165

Published: 2017

Journal Articles

Emerging Potential Roles of Lysyl-Oxidase-like 2 Stimulates Cancer Associated Fibroblasts Promoting Myelofibrosis of Myeloproliferative Neoplasms

Xiaoli Liu, PhD, Na Xu, MD, Chengyun Pan, MD, Xuan Zhou, MD, Qifa Liu, Ru Feng, Jing Sun, Hongsheng Zhou

Blood (2016) 128 (22): 5495.

https://doi.org/10.1182/blood.V128.22.5495.5495

Published: 2016

Journal Articles

LOXL2 Highly-Expressed Induce the Transition of Stromal Cells into Cancer-Associated Fibroblasts Which Maybe Involve in Myeloproliferative Neoplasms Progession

Na Xu, MD, Yuling Li, Xuan Zhou, MD, Lin Li, Qisi Lu, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 5207.

https://doi.org/10.1182/blood.V126.23.5207.5207

Published: 2015

Journal Articles

Impaired Lysophosphatidic Acid Receptor 3 Signaling in Mesenchymal Stromal Cells Promotes Multiple Myeloma Progression through Cellular Senescence and Transdifferentiation into Tumor-Associated Fibroblasts

Masahiko Kanehira, DVM, PhD, Tohru Fujiwara, MD PhD, Shinji Nakajima, MD PhD, Yoko Okitsu, MD PhD, Yasushi Ohnishi, MD PhD, Noriko Fukuhara, MD PhD, Ryo Ichinohasama, MD PhD, Hideo Harigae, MD PhD

Blood (2015) 126 (23): 1764.

https://doi.org/10.1182/blood.V126.23.1764.1764

Published: 2015

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) Tumor Cells Reprogram Lymphatic Fibroblasts into Cancer-Associated Fibroblasts (CAFs) That Contribute to Tumor Microenvironment (TME)-Driven Immune Privilege

Benedetta Apollonio, PhD, Nicole S. Nicholas, PhD, Lesley-Ann Sutton, Jon Salisbury, Piers E. Patten, BSc, MRCP, MRCPath, PhD, Shireen Kassam, FRCPath, MD MBBS, PhD, Stephen Devereux, FRCP, FRCPath, PhD, Rose Marie Amini, PhD, Richard Rosenquist, Alan G. Ramsay, PhD

Blood (2015) 126 (23): 1474.

https://doi.org/10.1182/blood.V126.23.1474.1474

Published: 2015

Journal Articles

Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts

Jerome Paggetti, Franziska Haderk, Martina Seiffert, Bassam Janji, Ute Distler, Wim Ammerlaan, Yeoun Jin Kim, Julien Adam, Peter Lichter, Eric Solary, Guy Berchem, Etienne Moussay

Blood (2015) 126 (9): 1106–1117.

https://doi.org/10.1182/blood-2014-12-618025

Published: 2015

Includes: Supplemental data

Journal Articles

Chronic Lymphocytic Leukemia-Exosomes Switch Endothelial and Mesenchymal Stromal Cells into Cancer-Associated Fibroblasts to Sustain Leukemic Cell Survival

Jerome Paggetti, Franziska Haderk, Martina Seiffert, Bassam Janji, Yeoun Jin Kim, Ute Diestler, Wim Ammerlaan, Peter Lichter, Eric Solary, Guy Berchem, Etienne Moussay

Blood (2014) 124 (21): 2927.

https://doi.org/10.1182/blood.V124.21.2927.2927

Published: 2014

NARROW

Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling

Single Cell Transcriptomic Analysis of the Multiple Myeloma Bone Marrow Identifies a Unique Inflammatory Stromal Cell Population Associated with TNF Signaling

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Lyn Kinase Contributes to the Reprogramming of Fibroblasts Promoting Chronic Lymphocytic Leukemia Progression

Heme Oxygenase-1 in Leukemia Cells Promotes Cancer Associated Fibroblasts Mediating Progression of Acute Lymphoblastic Leukemia

Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma

Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress

Exosomes Derived from Cancer Associated Fibroblasts Elicit Survival and Drug Resistance of Primary Lymphoma Cells

Extracellular Vesicles (EVs) Shape the Leukemic Microenvironment

Diffuse Large B-Cell Lymphoma Remodels the Fibroblastic Reticular Network That Acquires Aberrant Immunosuppressive Capabilities; Implications for the Regulation of Anti-Tumor Immunity in the Immuno-Oncology Era

Commonly Used Chemotherapy Drugs Differentially Determine Microenvironment-Mediated Protection, Via Mitochondrial Transfer, to B-Precursor Acute Lymphoblastic Leukaemia Cells

Heat Shock Factor 1 Reprograms the DLBCL Microenvironment to Evade Immune Surveillance and Support Tumor Growth

Tumor-Derived LOXL2 Is Highly Expressed in Myelofibrosis and Activating Mesenchymal Stem Cells Differentiate into Cancer Associated Fibroblasts In Vitro

Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance

Emerging Potential Roles of Lysyl-Oxidase-like 2 Stimulates Cancer Associated Fibroblasts Promoting Myelofibrosis of Myeloproliferative Neoplasms

LOXL2 Highly-Expressed Induce the Transition of Stromal Cells into Cancer-Associated Fibroblasts Which Maybe Involve in Myeloproliferative Neoplasms Progession

Impaired Lysophosphatidic Acid Receptor 3 Signaling in Mesenchymal Stromal Cells Promotes Multiple Myeloma Progression through Cellular Senescence and Transdifferentiation into Tumor-Associated Fibroblasts

Diffuse Large B-Cell Lymphoma (DLBCL) Tumor Cells Reprogram Lymphatic Fibroblasts into Cancer-Associated Fibroblasts (CAFs) That Contribute to Tumor Microenvironment (TME)-Driven Immune Privilege

Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts

Chronic Lymphocytic Leukemia-Exosomes Switch Endothelial and Mesenchymal Stromal Cells into Cancer-Associated Fibroblasts to Sustain Leukemic Cell Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only